A Phase IIb Study to Determine the Safety and Efficacy of Candidate INfluenza Vaccine MVA-NP+M1 in Combination With Licensed InaCTivated inflUenza Vaccine in adultS Aged 65 Years and Above
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 07 Oct 2017
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Acronyms INVICTUS
- Sponsors Vaccitech
- 07 Oct 2017 Status changed from planning to not yet recruiting.
- 29 Nov 2016 According to ISRCTN record, this (INVICTUS) study is planned for October 2017.
- 09 Nov 2016 According to Vaccitech media release, this study will run over 2017/8 and 2018/9 across the 2 influenza seasons.